Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

Keywords

BiologyMelanomaImmunotherapyCancer researchComputational biologyImmunologyImmune system

Affiliated Institutions

Related Publications

Cancer immunotherapy using checkpoint blockade

Antoni Ribas , Jedd D. Wolchok

The release of negative regulators of immune activation (immune checkpoints) that limit antitumor responses has resulted in unprecedented rates of long-lasting tumor responses i...

2018 Science 6236 citations

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

Suzanne L. Topalian , F. Stephen Hodi , Julie R. Brahmer +27 more

Anti-PD-1 antibody produced objective responses in approximately one in four to one in five patients with non-small-cell lung cancer, melanoma, or renal-cell cancer; the adverse...

2012 New England Journal of Medicine 12335 citations

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

Peng Jiang , Shengqing Gu , Deng Pan +12 more

2018 Nature Medicine 5230 citations

The biologic importance of tumor‐infiltrating lymphocytes

F. Stephen Hodi , Glenn Dranoff

Detailed pathologic analysis has delineated a close association between intratumoral CD 8 + cytotoxic T cells and favorable clinical outcomes in diverse cancers. Conversely, the...

2010 Journal of Cutaneous Pathology 55 citations

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Sanjeev Mariathasan , Shannon J. Turley , Dorothee Nickles +39 more

2018 Nature 5078 citations

Publication Info

Year: 2018
Type: article
Volume: 175
Issue: 4
Pages: 998-1013.e20
Citations: 1893
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1893

OpenAlex

Cite This

APA Style

                            
                                
                                    Moshe Sade-Feldman, 
                                
                                    Keren Yizhak, 
                                
                                    Stacey L. Bjorgaard
                                
                                et al.
                            
                            (2018). 
                            Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma. 
                            Cell
                            , 175
                            (4)
                            , 998-1013.e20.
                            https://doi.org/10.1016/j.cell.2018.10.038
                        

Identifiers

DOI: 10.1016/j.cell.2018.10.038